← Oscar Health, Inc. OSCR
Market Price
$32.71
Market Cap
$9.28B
P/E Ratio
N/A
Revenue (FY 2025)
↑39.0% YoY
$28.59M
3-Yr CAGR: -22.3%
Net Income
↓-1,842.5% YoY
-$443.15M
Net Margin: -1,549.9%
Free Cash Flow
↑11.4% YoY
$1.06B
FCF Yield: 11.41%
EPS (Diluted)
↓-1,790.0% YoY
$-1.69
Basic: $-1.69
Return on Equity
Efficiency
-45.3%
ROA: -9.6%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (OSCR)
All monetary values in millions ($M)
⚠️ YoY Data Quality Alert
- FY 2023: Revenue YoY (-74.7%) is identical to Gross Profit YoY (-74.7%). Verify the underlying Revenue and Gross Profit values for FY 2023 and FY 2022.
- FY 2024: Revenue YoY (+33.2%) is identical to Gross Profit YoY (+33.2%). Verify the underlying Revenue and Gross Profit values for FY 2024 and FY 2023.
- FY 2025: Revenue YoY (+39.0%) is identical to Gross Profit YoY (+39.0%). Verify the underlying Revenue and Gross Profit values for FY 2025 and FY 2024.
| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2020 | $462.8M | — | $90.5M | $-406.8M | — | $-14.16 | — | $222.7M | — | — |
| FY 2021 | $1,838.7M | +297.3% | $136.1M | $-572.6M | -40.7% | $-3.20 | +77.4% | $-181.7M | $-207.6M | — |
| FY 2022 | $61.0M | -96.7% | $61.0M | $-606.3M | -5.9% | $-2.85 | +10.9% | $380.3M | $351.3M | +269.2% |
| FY 2023 | $15.4M | -74.7% | $15.4M | $-270.7M | +55.3% | $-1.22 | +57.2% | $-272.2M | $-297.7M | -184.7% |
| FY 2024 | $20.6M | +33.2% | $20.6M | $25.4M | +109.4% | $0.10 | +108.2% | $978.2M | $950.3M | +419.2% |
| FY 2025 | $28.6M | +39.0% | $28.6M | $-443.2M | -1,842.5% | $-1.69 | -1,790.0% | $1,094.9M | $1,058.5M | +11.4% |
Valuation
Market Price
$32.71
Market Cap
$9.28B
Enterprise Value
$6.94B
P/E Ratio
N/A
P/B Ratio
10.09
FCF Yield
11.41%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
61.90%
Operating Margin
-1,386.20%
Net Margin
-1,549.86%
Return on Equity (ROE)
-45.33%
Return on Assets (ROA)
-9.61%
Asset Turnover
0.01x
Revenue 3-Yr CAGR
-22.34%
Financial Health & Liquidity
Current Ratio
0.95
Cash Ratio
0.57
Debt / Equity
0.440
Debt / Assets
0.093
Cash & Equivalents
$2.77B
Total Debt
$430.10M
Book Value / Share
$3.24
Cash Flow Efficiency
Operating Cash Flow
$1.09B
Capital Expenditures (CapEx)
$36.37M
Free Cash Flow
$1.06B
OCF / Revenue
3,829.10%
FCF / Revenue
3,701.89%
FCF 3-Yr CAGR
44.43%
Per Share Metrics
EPS (Diluted)
$-1.69
EPS (Basic)
$-1.69
Dividends / Share
N/A
Book Value / Share
$3.24
EPS YoY Growth
-1,790.00%
Balance Sheet (FY 2025)
Total Assets
$4.61B
Total Liabilities
$4.86B
Stockholders' Equity
$977.65M
Current Assets
$4.61B
Current Liabilities
$4.86B